← All trials
NCT01319448
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2011
- Primary completion
- Apr 1, 2013
- Completion date
- Apr 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 270
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- University of LondonLead sponsor
- Medical Research Council, The GambiaCollaborator
- University of IlorinOverall official - principal investigator
- Medical Research CouncilStudy director
- University of LondonStudy chair
- Wellcome TrustCollaborator
- University of IlorinCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.